Bower, R
GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic peptide agonists have several mechanisms of action, including reduction of gastric emptying, inhibition of glucagon secretion, beneficial changes in the intestinal microbiome, and direct effects on hypothalamic nuclei to enhance satiety (which promotes weight loss)
Realistic Expectations: 3 to 6 Months of Treatment After 12 weeks of GLP-1 therapy, most patients have lost 10 to 25 pounds and are experiencing stable appetite control, reduced food preoccupation, and improved relationship with portion sizes
Following the removal of these drugs from the FDA shortage list, the compounders trade group Outsourcing Facilities Association (OFA) filed lawsuits in an attempt to continue making the lucrative drugs
10.1007/s11064-022-03782-y 40 GuoY.ZhaoJ.LiuX.LuP.LiangF.WangX.et al (2025b)
The clot was removed by centrifugation at 1000 g for 15 min in a refrigerated centrifuge, the resulting supernatant constituting the serum
